½ÃÀ庸°í¼­
»óǰÄÚµå
1544092

¼¼°èÀÇ ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ ½ÃÀå

Intraoperative Neuromonitoring

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Industry Analysts, Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 196 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ ½ÃÀåÀº 2030³â±îÁö 55¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2023³â¿¡ 39¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ ½ÃÀåÀº 2023-2030³â CAGR 4.8%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 55¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ ÀÎ¼Ò½Ì ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µÀº CAGR 3.9%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 29¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¾Æ¿ô¼Ò½Ì ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 6.0%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 11¾ï ´Þ·¯, Áß±¹Àº CAGR 4.6%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ ½ÃÀåÀº 2023³â¿¡ 11¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 8¾ï 6,940¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2023-2030³â CAGRÀº 4.6%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 4.4%¿Í 4.2%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 4.9%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µÀ̶õ ¹«¾ùÀ̸ç, ¿Ö ¼ö¼ú ¾ÈÀü¼º¿¡ ÇʼöÀûÀΰ¡?

¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ(IONM)Àº ½Å°æ, ô¼ö, ³úÀÇ ÀÏºÎ¿Í °°Àº ½Å°æ ±¸Á¶ÀÇ ±â´ÉÀû ¹«°á¼ºÀ» ¸ð´ÏÅ͸µÇÏ´Â µ¥ »ç¿ëµÇ´Â ±â¼úÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ±¸Á¶ÀÇ Àü±âÀû Ȱµ¿À» ½Ç½Ã°£À¸·Î Çǵå¹éÇÔÀ¸·Î½á IONMÀº ¿Ü°ú Àǻ簡 Áß¿äÇÑ ½Å°æ °æ·ÎÀÇ ¼Õ»óÀ» ÇÇÇÏ°í ¼ö¼ú ÈÄ ½Å°æ Àå¾ÖÀÇ À§ÇèÀ» ÁÙÀÏ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù. ÀÌ ±â¼úÀº ƯÈ÷ ôÃß, ³ú, ¸»ÃʽŰæ°ú °ü·ÃµÈ ¼ö¼ú¿¡¼­ »ç¼ÒÇÑ ½Ç¼ö¶óµµ ½É°¢ÇÑ ÇÕº´ÁõÀ» À¯¹ßÇÒ ¼ö ÀÖÀ¸¹Ç·Î ¼ö¼ú ¾ÈÀüÀ» º¸ÀåÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇϸç, ¼ö¼ú °á°ú¸¦ °³¼±Çϰí À§ÇèÀ» ÃÖ¼ÒÈ­ÇÏ¸ç º¹ÀâÇÏ°í ¼¶¼¼ÇÑ ½Ã¼úÀÇ Àü¹ÝÀûÀÎ ¾ÈÀü¿¡ ±â¿©Çϱâ À§ÇØ IONMÀÇ »ç¿ëÀÌ Á¡Á¡ ´õ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. È®»êµÇ°í ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ ½ÃÀåÀ» ¾î¶»°Ô Çü¼ºÇϰí Àִ°¡?

±â¼úÀÇ ¹ßÀüÀº ƯÈ÷ ¸ð´ÏÅ͸µ ±â¼ú, ½ÅÈ£ ó¸® ¹× ¼ö¼ú ½Ã½ºÅÛ°úÀÇ ÅëÇÕ¿¡ ´ëÇÑ Çõ½ÅÀ» ÅëÇØ ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ ½ÃÀåÀ» Å©°Ô Çü¼ºÇϰí ÀÖ½À´Ï´Ù. ü¼º°¨°¢À¯¹ßÀüÀ§(SSEP), ¿îµ¿À¯¹ßÀüÀ§(MEP), ±ÙÀüµµ(EMG) µî ÷´Ü Àü±â»ý¸®ÇÐÀû ¸ð´ÏÅ͸µ ±â¼úÀÇ °³¹ß·Î ¼ö¼ú Áß ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ´Â ½Å°æ ±¸Á¶ÀÇ ¹üÀ§°¡ È®´ëµÇ¾î ¿Ü°úÀǻ翡°Ô ½Å°æ ±â´É¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ Çǵå¹éÀ» Á¦°øÇÕ´Ï´Ù. ½ÅÈ£ ó¸® ¾Ë°í¸®ÁòÀÇ °³¼±À¸·Î ½Å°æ ¸ð´ÏÅ͸µ µ¥ÀÌÅÍÀÇ Á¤È®¼º°ú ½Å·Ú¼ºÀÌ Çâ»óµÇ¾î ¼ö¼ú Áß ÀáÀçÀûÀÎ ¹®Á¦¸¦ º¸´Ù Á¤È®ÇÏ°Ô °¨ÁöÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ IONM°ú ÷´Ü ¿µ»ó ó¸® ±â¼ú ¹× ·Îº¿ ¼ö¼ú ½Ã½ºÅÛ°úÀÇ ÅëÇÕÀ¸·Î ½Å°æ ¸ð´ÏÅ͸µÀÇ È¿À²¼ºÀÌ ´õ¿í Çâ»óµÇ¾î º¹ÀâÇÑ ¼ö¼ú Áß ½Ã°¢È­ ¹× Á¦¾î°¡ ´õ¿í Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú ¹ßÀüÀº ¼ö¼úÀÇ ¾ÈÀü¼º°ú Ä¡·á °á°ú¸¦ Å©°Ô Çâ»ó½ÃÄÑ ´Ù¾çÇÑ ¼ö¼ú ºÐ¾ß¿¡¼­ IONMÀ» äÅÃÇϰí ÀÖ½À´Ï´Ù.

¿Ü°ú¼ö¼ú¿¡¼­ ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ¼ö¿ä´Â ¼ö¼úÀÇ º¹À⼺ Áõ°¡, ôÃß ¹× ½Å°æ ¼ö¼úÀÇ ¹ß»ý·ü Áõ°¡, ȯÀÚ ¾ÈÀü¿¡ ´ëÇÑ °ü½É Áõ°¡·Î ÀÎÇØ ¼ö¼ú ÇöÀå¿¡¼­ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¼ö¼úÀÌ Á¡Á¡ ´õ Á¤±³ÇØÁö°í À§ÇèÀÌ ³ô¾ÆÁü¿¡ µû¶ó ºÎÁÖÀÇ·Î ÀÎÇÑ ¼Õ»óÀ» ¹æÁöÇÏ°í ±àÁ¤ÀûÀÎ °á°ú¸¦ º¸ÀåÇϱâ À§ÇØ ½Å°æ ±¸Á¶ÀÇ ½Ç½Ã°£ ¸ð´ÏÅ͸µÀÇ Çʿ伺ÀÌ ÇʼöÀûÀÔ´Ï´Ù. ô¼ö ¼Õ»ó, ³úÁ¾¾ç, ¸»ÃÊ½Å°æ ¼Õ»ó µî º¹ÀâÇÑ ¿Ü°úÀû °³ÀÔÀÌ ÇÊ¿äÇÑ ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ¼ö¼ú ÈÄ ½Å°æÇÐÀû ÇÕº´Áõ À§ÇèÀ» ÁÙÀÌ´Â µ¥ µµ¿òÀÌ µÇ¹Ç·Î IONM¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¿Ü°úÀÇ»ç¿Í ȯÀÚµé »çÀÌ¿¡¼­ ½Å°æ ¸ð´ÏÅ͸µÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ¼ö¼úÀÇ ¾ÈÀü¼ºÀ» ³ôÀ̱â À§ÇØ IONMÀ» Ç¥ÁØÀ¸·Î äÅÃÇÏ´Â ÀÇ·áÁøÀÌ Áõ°¡Çϰí ÀÖ´Â °Íµµ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÇ·á ¾÷°è°¡ ȯÀÚÀÇ °á°ú¸¦ ¿ì¼±½ÃÇÏ°í ¼ö¼úÀÇ À§ÇèÀ» ÃÖ¼ÒÈ­Çϱâ À§ÇØ Áö¼ÓÀûÀ¸·Î ³ë·ÂÇÔ¿¡ µû¶ó ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ¼ö¿ä°¡ È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ ½ÃÀåÀÇ ¼ºÀåÀº ±â¼ú ¹ßÀü, ¼ö¼úÀÇ º¹À⼺ Áõ°¡, ȯÀÚ ¾ÈÀü Çâ»ó¿¡ ´ëÇÑ Á߿伺 µî ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ÃËÁø¿äÀÎ Áß Çϳª´Â ½Å°æ ¸ð´ÏÅ͸µ ±â¼úÀÇ ¹ßÀüÀ¸·Î ´Ù¾çÇÑ ¼ö¼ú Àü¹® ºÐ¾ß¿¡¼­ IONMÀÇ ±â´É°ú ¿ëµµ°¡ Å©°Ô È®´ëµÇ¾ú½À´Ï´Ù. ƯÈ÷ ½Å°æ ÇÕº´ÁõÀÌ ¹ß»ýÇϱ⠽¬¿î ôÃß, ½Å°æ¿Ü°ú ¹× Á¤Çü¿Ü°ú¼ö¼ú Áõ°¡´Â ¼ö¼úÀÇ ¼º°øÀ» º¸ÀåÇÏ´Â Áß¿äÇÑ Åø·Î¼­ IONM¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÃÖ¼Ò Ä§½À ¼ö¼ú ±â¹ýÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÏ°í ·Îº¿ °øÇÐ ¹× ³»ºñ°ÔÀÌ¼Ç Åø¿Í °°Àº ÷´Ü ¼ö¼ú ½Ã½ºÅÛ°ú IONMÀÌ ÅëÇÕµÇ¾î ¼ö¼úÀÇ Á¤È®¼º°ú ¾ÈÀü¼ºÀ» ³ôÀÓÀ¸·Î½á ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÇ·á ºñ¿ë Àý°¨°ú ȯÀÚ °á°ú °³¼±¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ºñ¿ëÀÌ ¸¹ÀÌ µå´Â ¼ö¼ú ÈÄ ÇÕº´ÁõÀ» ¿¹¹æÇϱâ À§ÇÑ ¿¹¹æÃ¥À¸·Î IONMÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ ¿Ü°ú¼ö¼ú ȯ°æ¿¡ Áö¼ÓÀûÀ¸·Î ¿µÇâÀ» ¹ÌÄ¡¸é¼­ ¼ö¼ú Áß º¸´Ù Á¤±³ÇÏ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â Á¾ÇÕÀûÀÎ ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀå ȯ°æÀº Áö¼ÓÀûÀ¸·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹(ÃÑ 46°Ç)

  • Cadwell Industries, Inc.
  • Computational Diagnostics, Inc.
  • Medtronic PLC
  • Natus Medical, Inc.
  • NuVasive, Inc.
  • SpecialtyCare

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

  • ½ÃÀå °³¿ä
  • ÁÖ¿ä ±â¾÷
  • ½ÃÀå µ¿Çâ°ú ÃËÁø¿äÀÎ
  • ¼¼°è ½ÃÀåÀÇ Àü¸Á

Á¦3Àå ½ÃÀå ºÐ¼®

  • ¹Ì±¹
  • ij³ª´Ù
  • ÀϺ»
  • Áß±¹
  • À¯·´
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • ÀÌÅ»¸®¾Æ
  • ¿µ±¹
  • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ±âŸ Áö¿ª

Á¦4Àå °æÀï

KSA 24.09.04

Global Intraoperative Neuromonitoring Market to Reach US$5.5 Billion by 2030

The global market for Intraoperative Neuromonitoring estimated at US$3.9 Billion in the year 2023, is expected to reach US$5.5 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Insourced Intraoperative Neuromonitoring, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$2.9 Billion by the end of the analysis period. Growth in the Outsourced Intraoperative Neuromonitoring segment is estimated at 6.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.1 Billion While China is Forecast to Grow at 4.6% CAGR

The Intraoperative Neuromonitoring market in the U.S. is estimated at US$1.1 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$869.4 Million by the year 2030 trailing a CAGR of 4.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.4% and 4.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Global Intraoperative Neuromonitoring Market - Key Trends & Drivers Summarized

What Is Intraoperative Neuromonitoring and Why Is It Crucial for Surgical Safety?

Intraoperative neuromonitoring (IONM) is a technique used during surgeries to monitor the functional integrity of neural structures such as nerves, spinal cord, and parts of the brain. By providing real-time feedback on the electrical activity of these structures, IONM helps surgeons avoid injury to critical neural pathways, thereby reducing the risk of postoperative neurological deficits. This technique is crucial for surgical safety, especially in procedures involving the spine, brain, and peripheral nerves, where even a minor error can lead to significant complications. The use of IONM has become increasingly widespread as it enhances surgical outcomes, minimizes risks, and contributes to the overall safety of complex and delicate procedures.

How Are Technological Advancements Shaping the Intraoperative Neuromonitoring Market?

Technological advancements are significantly shaping the intraoperative neuromonitoring market, particularly through innovations in monitoring techniques, signal processing, and integration with surgical systems. The development of advanced electrophysiological monitoring techniques, such as somatosensory evoked potentials (SSEPs), motor evoked potentials (MEPs), and electromyography (EMG), is expanding the range of neural structures that can be monitored during surgery, providing surgeons with comprehensive feedback on neural function. Improvements in signal processing algorithms are enhancing the accuracy and reliability of neuromonitoring data, enabling more precise detection of potential issues during surgery. Additionally, the integration of IONM with advanced imaging technologies and robotic surgical systems is further enhancing the effectiveness of neuromonitoring, allowing for better visualization and control during complex procedures. These technological trends are driving the adoption of IONM across various surgical disciplines, as they offer significant improvements in surgical safety and outcomes.

Why Is There an Increasing Demand for Intraoperative Neuromonitoring in Surgical Practices?

The demand for intraoperative neuromonitoring is increasing in surgical practices due to the growing complexity of surgeries, the rising incidence of spinal and neurosurgical procedures, and the increasing emphasis on patient safety. As surgical procedures become more advanced and involve higher risks, the need for real-time monitoring of neural structures has become essential to prevent inadvertent damage and ensure positive outcomes. The rising prevalence of conditions such as spinal disorders, brain tumors, and peripheral nerve injuries, which often require complex surgical interventions, is also driving demand for IONM, as it helps reduce the risk of postoperative neurological complications. Additionally, the growing awareness of the benefits of neuromonitoring among surgeons and patients is contributing to the market’s expansion, as more healthcare providers adopt IONM as a standard practice to enhance surgical safety. As the healthcare industry continues to prioritize patient outcomes and minimize surgical risks, the demand for intraoperative neuromonitoring is expected to grow.

What Factors Are Driving the Growth in the Intraoperative Neuromonitoring Market?

The growth in the intraoperative neuromonitoring market is driven by several factors related to technological advancements, the increasing complexity of surgical procedures, and the emphasis on improving patient safety. One of the primary drivers is the advancement in neuromonitoring technologies, which has significantly expanded the capabilities and applications of IONM in various surgical specialties. The rising number of spinal, neurosurgical, and orthopedic procedures, which are particularly prone to neural complications, is also fueling demand for IONM as a critical tool for ensuring surgical success. The growing adoption of minimally invasive surgical techniques and the integration of IONM with advanced surgical systems, such as robotics and navigation tools, are further propelling market growth by enhancing the precision and safety of surgeries. Additionally, the increasing focus on reducing healthcare costs and improving patient outcomes is driving the adoption of IONM as a preventive measure to avoid costly postoperative complications. As these factors continue to influence the surgical landscape, the intraoperative neuromonitoring market is expected to experience sustained growth, driven by the need for more advanced, reliable, and comprehensive monitoring solutions during surgery.

Select Competitors (Total 46 Featured) -

  • Cadwell Industries, Inc.
  • Computational Diagnostics, Inc.
  • Medtronic PLC
  • Natus Medical, Inc.
  • NuVasive, Inc.
  • SpecialtyCare

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Intraoperative Neuromonitoring - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Emphasis on Patient Safety Spurs Adoption of Intraoperative Neuromonitoring (IONM)
    • Advancements in Neuromonitoring Technologies Propel Market Growth
    • Shift Towards Minimally Invasive Surgeries Expands Market Opportunities for IONM
    • Technological Innovations Enhance the Accuracy and Reliability of Neuromonitoring
    • Increasing Use of IONM in Complex Spinal and Neurosurgical Procedures
    • Role of Intraoperative Neuromonitoring in Reducing Postoperative Complications
    • Growing Importance of Multimodal Monitoring Techniques in Surgery
    • Advancements in Real-Time Data Analysis and Interpretation Boost Market Adoption
    • Impact of Regulatory Standards and Guidelines on the Adoption of IONM
    • Expansion of IONM in Cardiovascular and Orthopedic Surgeries
    • Role of IONM in Enhancing Outcomes in Pediatric and Geriatric Surgery
    • Growing Demand for Remote Monitoring and Tele-IONM Services
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Intraoperative Neuromonitoring Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Intraoperative Neuromonitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Intraoperative Neuromonitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Intraoperative Neuromonitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Insourced by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Insourced by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Insourced by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Outsourced by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Outsourced by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Outsourced by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Intraoperative Neuromonitoring Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 11: USA Recent Past, Current & Future Analysis for Intraoperative Neuromonitoring by Type - Insourced and Outsourced - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 12: USA Historic Review for Intraoperative Neuromonitoring by Type - Insourced and Outsourced Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: USA 16-Year Perspective for Intraoperative Neuromonitoring by Type - Percentage Breakdown of Value Sales for Insourced and Outsourced for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 14: Canada Recent Past, Current & Future Analysis for Intraoperative Neuromonitoring by Type - Insourced and Outsourced - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 15: Canada Historic Review for Intraoperative Neuromonitoring by Type - Insourced and Outsourced Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: Canada 16-Year Perspective for Intraoperative Neuromonitoring by Type - Percentage Breakdown of Value Sales for Insourced and Outsourced for the Years 2014, 2024 & 2030
  • JAPAN
    • Intraoperative Neuromonitoring Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 17: Japan Recent Past, Current & Future Analysis for Intraoperative Neuromonitoring by Type - Insourced and Outsourced - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Japan Historic Review for Intraoperative Neuromonitoring by Type - Insourced and Outsourced Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: Japan 16-Year Perspective for Intraoperative Neuromonitoring by Type - Percentage Breakdown of Value Sales for Insourced and Outsourced for the Years 2014, 2024 & 2030
  • CHINA
    • Intraoperative Neuromonitoring Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 20: China Recent Past, Current & Future Analysis for Intraoperative Neuromonitoring by Type - Insourced and Outsourced - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: China Historic Review for Intraoperative Neuromonitoring by Type - Insourced and Outsourced Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: China 16-Year Perspective for Intraoperative Neuromonitoring by Type - Percentage Breakdown of Value Sales for Insourced and Outsourced for the Years 2014, 2024 & 2030
  • EUROPE
    • Intraoperative Neuromonitoring Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 23: Europe Recent Past, Current & Future Analysis for Intraoperative Neuromonitoring by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: Europe Historic Review for Intraoperative Neuromonitoring by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: Europe 16-Year Perspective for Intraoperative Neuromonitoring by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Intraoperative Neuromonitoring by Type - Insourced and Outsourced - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Intraoperative Neuromonitoring by Type - Insourced and Outsourced Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Intraoperative Neuromonitoring by Type - Percentage Breakdown of Value Sales for Insourced and Outsourced for the Years 2014, 2024 & 2030
  • FRANCE
    • Intraoperative Neuromonitoring Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 29: France Recent Past, Current & Future Analysis for Intraoperative Neuromonitoring by Type - Insourced and Outsourced - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: France Historic Review for Intraoperative Neuromonitoring by Type - Insourced and Outsourced Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: France 16-Year Perspective for Intraoperative Neuromonitoring by Type - Percentage Breakdown of Value Sales for Insourced and Outsourced for the Years 2014, 2024 & 2030
  • GERMANY
    • Intraoperative Neuromonitoring Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 32: Germany Recent Past, Current & Future Analysis for Intraoperative Neuromonitoring by Type - Insourced and Outsourced - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Germany Historic Review for Intraoperative Neuromonitoring by Type - Insourced and Outsourced Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Germany 16-Year Perspective for Intraoperative Neuromonitoring by Type - Percentage Breakdown of Value Sales for Insourced and Outsourced for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 35: Italy Recent Past, Current & Future Analysis for Intraoperative Neuromonitoring by Type - Insourced and Outsourced - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Italy Historic Review for Intraoperative Neuromonitoring by Type - Insourced and Outsourced Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Italy 16-Year Perspective for Intraoperative Neuromonitoring by Type - Percentage Breakdown of Value Sales for Insourced and Outsourced for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Intraoperative Neuromonitoring Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 38: UK Recent Past, Current & Future Analysis for Intraoperative Neuromonitoring by Type - Insourced and Outsourced - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: UK Historic Review for Intraoperative Neuromonitoring by Type - Insourced and Outsourced Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: UK 16-Year Perspective for Intraoperative Neuromonitoring by Type - Percentage Breakdown of Value Sales for Insourced and Outsourced for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 41: Rest of Europe Recent Past, Current & Future Analysis for Intraoperative Neuromonitoring by Type - Insourced and Outsourced - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Rest of Europe Historic Review for Intraoperative Neuromonitoring by Type - Insourced and Outsourced Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Rest of Europe 16-Year Perspective for Intraoperative Neuromonitoring by Type - Percentage Breakdown of Value Sales for Insourced and Outsourced for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Intraoperative Neuromonitoring Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 44: Asia-Pacific Recent Past, Current & Future Analysis for Intraoperative Neuromonitoring by Type - Insourced and Outsourced - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Asia-Pacific Historic Review for Intraoperative Neuromonitoring by Type - Insourced and Outsourced Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Asia-Pacific 16-Year Perspective for Intraoperative Neuromonitoring by Type - Percentage Breakdown of Value Sales for Insourced and Outsourced for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 47: Rest of World Recent Past, Current & Future Analysis for Intraoperative Neuromonitoring by Type - Insourced and Outsourced - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Rest of World Historic Review for Intraoperative Neuromonitoring by Type - Insourced and Outsourced Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Rest of World 16-Year Perspective for Intraoperative Neuromonitoring by Type - Percentage Breakdown of Value Sales for Insourced and Outsourced for the Years 2014, 2024 & 2030

IV. COMPETITION

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦